Navigation Links
Depo Provera Side Effects examined at Congressional Briefing with Rebecca Project for Human Rights, Congressman William Lacy Clay and Other Human Rights Leaders
Date:9/17/2013

WASHINGTON, Sept. 17, 2013 /PRNewswire-USNewswire/ -- U.S. Congressman William Lacy Clay, Jr. (MO), Member of the U.S. Congress and Congressional Black Caucus will hold a Congressional briefing examining Pfizer and health providers targeting women of color to be primary consumers of the carcinogenic contraceptive drug Depo Provera, by concealing of FDA Black Box Warnings and minimizing life-threatening and debilitating side effects. This Depo Provera briefing, in collaboration with the Rebecca Project for Human Rights, is to educate and inform women about lethal side effects of the Depo Provera shot. It will be held at the US Capitol Hill Campus on September 20, 2013 at 3:30PM during the CBC conference week at the Capitol Visitors Center Auditorium. 

Imani Walker, Executive Director of the Rebecca Project stated, "our nonpartisan anti-Depo Provera advocacy is about protecting Black women's reproductive health and protecting low-income communities, because Black women experience significant health disparities."  According to the Centers for Disease Control (CDC), the leading causes of death for Black women are: heart disease, cancer, HIV/AIDS stroke, and diabetes. Furthermore, medical research indicates the use of Depo Provera can cause or exacerbate all those diseases. Therefore, it is imperative that women are counseled and provided informed consent about harm. 

In June 2013, Rebecca Project for Human Rights published a policy report: Depo-Provera: Deadly Reproductive Violence. Kwame Fosu, Policy Director for the Rebecca Project for Human Rights explains, "this is a definitive report that details incidents of misconduct by Pfizer major health providers." In addition, the Rebecca Project analysis also examines reported concerns of Depo Provera research in Ghana.

Pastor Lennox Abrigo, who is President, National Action Network DC Chapter, and President of the Civil & Human Rights Depo Provera Coalition said, "this Depo Provera briefing is going to be a respectful, thoughtful discussion about the dignity and health of Black women, and women of color, in the United States and globally. Our community's harm and voices have to be heard by our elected leaders, Pfizer, Planned Parenthood and all Public Health institutions that continue to promote this dangerous drug without Black Box warnings."

Other health and women's rights leaders participating at the Congressional briefing are: Dr. Charlotte Charity Abaka, former Chairperson of Committee on the Elimination of Discrimination Against Women (CEDAW); Grace Akallo, Executive Director, United Africans for Women and Children Rights; Rev. Brook Parker Bello, Executive Director, Above the Noise; Dr. Joel Brind, Professor of Biology and Endocrinology, CUNY; Ms. Lisa Davis, Chairperson of Black is Back Coalition Healthcare Working Group; Reverend Marcia Dyson, The Dyson Report; Kwame Fosu, Policy Director, Rebecca Project for Human Rights; Dr. Steve Minkin, Public Health HIV AIDS Expert; Elize Lotter, a South Africa Human Rights Advocate permanently harmed by Depo Provera; Jesse Morrow, Social Reform Director, Church of Scientology, National Affairs Office; Professor Charles Ogletree, Harvard Law Professor; Reverend Marvin Owens, Jr., Senior Pastor of Michigan Park; Elaine Riddick, Women's Rights Activist, forcibly sterilized in 1968 at age 13 and fought back to help secure a $10 million settlement for victims; Minister Dr. Randy Short, Social Justice Minister and National Spokesperson and President of the Clergy Coalition; and Imani Walker, Executive Director, Rebecca Project for Human Rights.

For more information about Depo Provera, please contact Kwame Fosu or Imani Walker at 202-406-0911 or 202-265-3906, or go to the Rebecca Project website at http://www.rebeccaproject.org/.


'/>"/>
SOURCE Rebecca Project for Human Rights
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Mechanism for Cardiac Effects of Trevena Angiotensin Receptor Biased Ligands Examined in Published Study
2. Synthetically Optimized HIF-1 Alpha DNA Delivered with Inovios Electroporation Technology Provides Significant Therapeutic Effects for Peripheral Arterial Disease in Animal Model
3. Side Effects Limit Prescription Drug Compliance
4. Garcinia Cambogia Extract Truth Exposed: Reviews, Side Effects & Where To Buy
5. Life After Failing TVM Treatments is a Rollercoaster of Side Effects for Women
6. Adverse Effects in AIM-HIGH trial of Niaspan are Consistent With the Results Reported From HPS2-THRIVE Trial of ER Niacin Plus Laropiprant
7. Star Scientific and Rock Creek Pharmaceuticals Report on the Beneficial Nutritional Effects of Anatabine in an Animal Model of Ulcerative Colitis
8. Niacin Causes Serious Unexpected Side-effects, but no Worthwhile Benefits, for Patients who are at Increased Risk of Heart Attacks and Strokes
9. New Study Shows Cannabis Effects on Driving Skills
10. Fox News Medical Contributor Explains Study of Side Effects from Prostate-Cancer Treatments
11. Star Scientific Reports Publication of First Peer-Reviewed Article on the Effects of Anatabine in an Animal Model of Multiple Sclerosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... , Feb. 12 2016  OMS Supply, a ... and medical practitioners, announced today the recent launching of ... visitors a variety of features that enhance the user ... surgery supplies. --> ... a fairly new company that started in early 2016, ...
(Date:2/11/2016)... 2016 - Cardiac Marker ... Medicine and Cancer Therapy. - European Point of ... Markets. - Key Diagnostic Testing Markets. - ... in Genetic Testing. - Molecular Diagnostics in Infectious ... Over-the-Counter Diagnostic Products World Markets. - Point of ...
(Date:2/11/2016)... Feb. 11, 2016  Kindred Biosciences, Inc. (NASDAQ: ... improving the lives of pets, today announced the submission ... New Animal Drug Application (NADA) for Zimeta™ (dipyrone injection, ... (KB0120) of Zimeta for the control of pyrexia (fever) ... --> --> The Chemistry, ...
Breaking Medicine Technology:
(Date:2/13/2016)... ... 13, 2016 , ... In its newly released Infusion Therapy ... should be used to ensure patient safety when placing an IV catheter. A ... the use of vein visualization technology in patients with difficult venous access or ...
(Date:2/13/2016)... ... February 13, 2016 , ... DDi ... Management Solution Providers list for its expertise in eClinical Solutions. DDi has built ... serve the technology needs of global clients. DDi provides smarter technology for Clinical ...
(Date:2/12/2016)... Seattle, WA, and Washington, DC (PRWEB) , ... ... ... PATH and the Siemens Foundation today announced a new initiative—the Siemens ... technologies for low-resource settings. The partnership will recruit top students from U.S. ...
(Date:2/12/2016)... PA (PRWEB) , ... February 12, 2016 , ... Each ... event will be held in Anaheim, CA at the Anaheim Convention Center. Almost 10,000 ... can see new therapy products in action, learn more about their chosen field and ...
(Date:2/12/2016)... ... February 12, 2016 , ... ... at Zuckerberg San Francisco General Hospital on April 5-7. The series is a ... create new habits. The workshops cover a broad range of topics, including coaching ...
Breaking Medicine News(10 mins):